The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Optimal combination therapy for advanced colorectal cancer: An examination of synergy and antagonism with EGFR inhibition.
Nilesh Vora
No relevant relationships to disclose
Steven Evans
Employment or Leadership Position - Rational Therapeutics
Paula J Bernard
Employment or Leadership Position - Rational Therapeutics
Federico Francisco
Employment or Leadership Position - Rational Therapeutics
Robert Alan Nagourney
Employment or Leadership Position - Rational Therapeutics
Consultant or Advisory Role - Rational Therapeutics
Stock Ownership - Rational Therapeutics